cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay
K-Number: K160571 · 2016-12-19
Device Summary
Frequently Asked Questions
What is the cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay?
cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay is a medical device that received FDA 510(k) clearance on 2016-12-19. The listed applicant is Roche Diagnostics Operations (Rdo). The 510(k) number is K160571.
When did cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay receive FDA 510(k) clearance?
cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay received FDA 510(k) clearance on 2016-12-19, under 510(k) number K160571.
Who is the listed applicant for cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay?
The FDA 510(k) record lists Roche Diagnostics Operations (Rdo) as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay?
The FDA product code for cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay is PDJ.
Other records listing Roche Diagnostics Operations (Rdo) as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: PDJ)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.